The rest of the 100 (in alphabetical order): Lana Ghanem, Hikma Ventures
Lana Ghanem has been managing director of Hikma Ventures since August 2015 having officially joined the Lebanon-based generic drugs company three years earlier within the office of the CEO covering corporate strategy and development. She was a summer associate in 2011 while completing her MBA from Harvard.
Going from that to “establishing Hikma Ventures has been an eye-opening experience with a steep learning curve”, she said.
“It enabled various Hikma teams, including sales and marketing, business development, legal and operations, to gain exposure to emerging innovative technologies that will change healthcare. Digital health is becoming more of a necessity than a nice-to-have.”
She said her highlights from the past year included hiring Hamzeh Abdul-Hadi, a GCV Rising Star, as an associate, and making two investments in US-based companies, Chrono Therapeutics and Propeller Health.
She is a board observer at both portfolio companies, but looking for more deals, and has been working on “building Hikma Ventures’ reputation” through connections with more than 120 venture capital firms globally.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.